Original Article

The Effect of Type 2 Diabetes Mellitus on Platelet Aggregation in Patients who Underwent Percutaneous Transluminal Coronary Angioplasty

Volume 4 · Issue 3 Publish Date: March 21, 2022
Abdi Sağcan
Atakalp Heart Hospital, Izmir, Turkiye
Serdar Bedii Omay
Ege University, Medical School, Department of Internal Medicine, Izmir, Turkey
Mustafa Akın
Ege University, Faculty of Medicine, Department of Cardiology, Izmir, Turkey
Sağcan, A., Omay, S. B., & Akın, M. (2022). The Effect of Type 2 Diabetes Mellitus on Platelet Aggregation in Patients who Underwent Percutaneous Transluminal Coronary Angioplasty . Endocrinology Research and Practice, 4(3), -. Retrieved from https://endocrinolrespract.org/index.php/pub/article/view/124

Abstract

ABSTRACT
In type 2 (NIDDM) diabetic patients it has been expressed that adenosin diphosphate (ADP) triggered platelet aggregation response increases related to a decreased level of platelet guanilate cyclase. Ten patients with type 2 diabetes mellitus and 25 nondiabetic patients who had succesful percutaneous transluminal coronary angioplasty (PTCA) were studied to investigate the effects of type 2 DM on the response of collagen triggered in vitro platelet aggregation in PTCA patients. Platelet rich plasma (PRP) samples from the patients before and after PTCA were treated with in-vitro collagen and platelet aggregation slopes were calculated via the turbidometric method. The activation percentage and the ratio of changes after PTCA in the study cases were measured from these slopes and data were compared by non-parametric methods. Change in collagen induced activation of platelet aggregation in both wave I and wave II was significantly greater (p<0.05) in the type 2 diabetes mellitus group. The ratio of restenosis seen in the control coronary angiography performed 6 months after interventions was found to be significantly higher in the type 2 diabetes mellitus group (p<0.05). Effects of interventions on haematologic parameters (number of platelets, ACT value) were common in both groups. We did not find any significant changes in the left ventricular ejection fraction (LVEF), number of lesions, percent stenosis of arteries before interventions, duration and success of interventions, diameter of balloons used and duration of balloon inflation between groups (p>0.05). In conclusion, collagen induced platelet aggregation response and incidence of thrombosis were greater in patients with type 2 diabetes mellitus than in nondiabetics. This makes us think that type 2 diabetes mellitus patients might need more potent antiplatelet therapy before PTCA after blood glucose levels have been regulated.
Article Info
Published In
Journal Endocrinology Research and Practice
Volume / Issue Volume 4 · Issue 3
Pages -
History
Published Online March 21, 2022
Copyright
Affiliations
Abdi Sağcan
Atakalp Heart Hospital, Izmir, Turkiye
Serdar Bedii Omay
Ege University, Medical School, Department of Internal Medicine, Izmir, Turkey
Mustafa Akın
Ege University, Faculty of Medicine, Department of Cardiology, Izmir, Turkey
Cite this Article
Sağcan, A., Omay, S. B., & Akın, M. (2022). The Effect of Type 2 Diabetes Mellitus on Platelet Aggregation in Patients who Underwent Percutaneous Transluminal Coronary Angioplasty . Endocrinology Research and Practice, 4(3), -. Retrieved from https://endocrinolrespract.org/index.php/pub/article/view/124
Outlines